Idexx Laboratories Inc (IDXX):企業の財務・戦略的SWOT分析

◆英語タイトル:Idexx Laboratories Inc (IDXX) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14018
◆発行会社(調査会社):GlobalData
◆発行日:2019年2月
◆ページ数:64
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Idexx Laboratories Inc (IDXX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Idexx Laboratories Inc (IDEXX) develops, manufactures, and distributes products and provides services for the companion animal veterinary, poultry and livestock, dairy and water testing markets. The company offers point-of-care veterinary diagnostic products, microbiological contaminant testing products (in water), livestock and poultry diagnostic and health-monitoring products, antibiotic residue testing products (in milk), veterinary reference laboratory diagnostics and consulting services and practice management and diagnostic imaging systems and services. IDEXX also sells a line of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. It operates along with its subsidiaries in the Americas, Europe, the Middle East, Africa and Asia-Pacific. IDEXX is headquartered in Westbrook, Maine, the US.

Idexx Laboratories Inc Key Recent Developments

Feb 01,2019: IDEXX Laboratories announces fourth quarter and full year 2018 results
Jan 21,2019: Idexx Introduces new canine progesterone test for Catalyst Dx & Catalyst One chemistry analyzers
Nov 01,2018: IDEXX Laboratories announces third quarter results
Oct 08,2018: Idexx chief medical officer plans 2019 retirement
Sep 10,2018: IDEXX Pseudalert Test accepted as Global ISO Standard

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Idexx Laboratories Inc – Key Facts
Idexx Laboratories Inc – Key Employees
Idexx Laboratories Inc – Key Employee Biographies
Idexx Laboratories Inc – Major Products and Services
Idexx Laboratories Inc – History
Idexx Laboratories Inc – Company Statement
Idexx Laboratories Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Idexx Laboratories Inc – Business Description
Business Segment: Companion Animal Group
Overview
Performance
Business Segment: Livestock and Poultry Diagnostics
Overview
Performance
Business Segment: Other
Overview
Performance
Business Segment: Water
Overview
Performance
Geographical Segment: Americas
Target Markets
Performance
Geographical Segment: Asia Pacific Region
Target Markets
Performance
Geographical Segment: Europe, the Middle East and Africa
Target Markets
Performance
R&D Overview
Idexx Laboratories Inc – Corporate Strategy
Idexx Laboratories Inc – SWOT Analysis
SWOT Analysis – Overview
Idexx Laboratories Inc – Strengths
Idexx Laboratories Inc – Weaknesses
Idexx Laboratories Inc – Opportunities
Idexx Laboratories Inc – Threats
Idexx Laboratories Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Idexx Laboratories Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Idexx Laboratories Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
Idexx Laboratories Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 01, 2019: IDEXX Laboratories announces fourth quarter and full year 2018 results
Jan 21, 2019: Idexx Introduces new canine progesterone test for Catalyst Dx & Catalyst One chemistry analyzers
Nov 01, 2018: IDEXX Laboratories announces third quarter results
Sep 10, 2018: TOPC : II-VI Incorporated Unveils Dual Port Pluggable OTDR[Newswire : MarketLine - GNW RSS]
Sep 10, 2018: IDEXX Pseudalert Test accepted as Global ISO Standard
Sep 10, 2018: Parex Announces Capachos Andina Discovery[Newswire : MarketLine - GNW]
Sep 10, 2018: Solar Alliance Completes Project for AAMCO in Tennessee as Part of Expanded Channel Partner Program[Newswire : MarketLine - GNW]
Sep 10, 2018: Prairie Provident Announces Further Princess Drilling Program Update[Newswire : MarketLine - GNW]
Sep 10, 2018: MenaITech First in Region to Implement Virtual Sign Language Avatar[Newswire : MarketLine – PRN ]
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Idexx Laboratories Inc, Key Facts
Idexx Laboratories Inc, Key Employees
Idexx Laboratories Inc, Key Employee Biographies
Idexx Laboratories Inc, Major Products and Services
Idexx Laboratories Inc, History
Idexx Laboratories Inc, Other Locations
Idexx Laboratories Inc, Subsidiaries
Idexx Laboratories Inc, Key Competitors
Idexx Laboratories Inc, Ratios based on current share price
Idexx Laboratories Inc, Annual Ratios
Idexx Laboratories Inc, Annual Ratios (Cont...1)
Idexx Laboratories Inc, Annual Ratios (Cont...2)
Idexx Laboratories Inc, Interim Ratios
Idexx Laboratories Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Idexx Laboratories Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
Idexx Laboratories Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Idexx Laboratories Inc, Performance Chart (2014 - 2018)
Idexx Laboratories Inc, Ratio Charts
Idexx Laboratories Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Idexx Laboratories Inc, Medical Equipment, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Idexx Laboratories Inc (IDXX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vectura Group plc:企業の戦略・SWOT・財務分析
    Vectura Group plc - Strategy, SWOT and Corporate Finance Report Summary Vectura Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Biohit Oyj (BIOBV):医療機器:M&Aディール及び事業提携情報
    Summary Biohit Oyj (Biohit) is a biotechnology company that offers research and early diagnosis processing products. The company’s products comprise acetaldehyde binding products, diagnostic tests, dysbiosis test, microplate readers and washers, monoclonal antibodies, and pipettes. It targets therap …
  • The Netherlands Cancer Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary The Netherlands Cancer Institute (NCI) is a research institute that offers cancer research and treatment services. The institute conducts research in the areas of cell biology, diagnostic oncology, medical oncology, molecular carcinogenesis, biochemistry, biological stress response, gene reg …
  • KDDI Corporation:企業の戦略・SWOT・財務情報
    KDDI Corporation - Strategy, SWOT and Corporate Finance Report Summary KDDI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • GlobalSCAPE Inc (GSB):企業の財務・戦略的SWOT分析
    Summary GlobalSCAPE Inc (GlobalSCAPE) is a technology company that offers secure information exchange solutions. The company offers EFT platform products such as EFT enterprise, EFT express, public and private cloud, collaboration, automation and efficiency, protocols, security, compliance and analy …
  • MSIG Holdings (Asia) Pte. Ltd.:企業の戦略・SWOT・財務情報
    MSIG Holdings (Asia) Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary MSIG Holdings (Asia) Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Laredo Petroleum Inc (LPI):企業の財務・戦略的SWOT分析
    Laredo Petroleum Inc (LPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Bristol-Myers Squibb Co (BMY):医療機器:M&Aディール及び事業提携情報
    Summary Bristol-Myers Squibb Co (BMS) is a specialty biopharmaceutical company that carries out the discovery, development, licensing, manufacturing, marketing, distribution and sale of medicines to patients with serious diseases. Its primary focus is on cancer, cardiovascular, immunology and virolo …
  • Respiri Ltd (RSH):医療機器:M&Aディール及び事業提携情報
    Summary Respiri Ltd (Respiri), formerly iSonea Ltd, is a medical technology company that develops non-invasive medical devices and mobile health applications to improve the management of chronic respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). The company’s prop …
  • Michael J Fox Foundation for Parkinson’s Research:製薬・医療:M&Aディール及び事業提携情報
    Summary Michael J Fox Foundation for Parkinson's Research (Michael J. Fox) is a research foundation that conducts research on Parkinson's disease. The foundation offers research and development of therapies. It provides drug development and other research activities. Michael J. Fox offers treatments …
  • Toronto Hydro Corporation:企業の戦略的SWOT分析
    Toronto Hydro Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Westgold Resources Ltd (WGX):企業の財務・戦略的SWOT分析
    Westgold Resources Ltd (WGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Trevena Inc (TRVN)-製薬・医療分野:企業M&A・提携分析
    Summary Trevena Inc (Trevena) is a biopharmaceutical company that discovers and develops G-protein coupled receptor targeted medicines. The company’s products include RV027, TRV130, TRV734 and TRV250. Its TRV027 is an intravenous drug used for the treatment of acute heart failure in combination with …
  • Banco Hipotecario SA (BHIP3):企業の財務・戦略的SWOT分析
    Banco Hipotecario SA (BHIP3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Ergomed Plc (ERGO):企業の財務・戦略的SWOT分析
    Summary Ergomed Plc (Ergomed), formerly Ergomed Clinical Research Ltd, is a drug development and clinical research services provider. The company provides various services such as regulatory and quality management, biostatistics, study management, clinical data management, medical writing, and other …
  • Noble Corporation Plc (NE):石油・ガス:M&Aディール及び事業提携情報
    Summary Noble Corporation Plc (Noble) is an offshore drilling contractor for the oil and gas industry. It provides contract drilling services with its fleet of mobile offshore drilling units. The company’s offshore rig fleet operates in the global market and provides contract drilling services. Nobl …
  • Capture Vascular Inc:医療機器:M&Aディール及び事業提携情報
    Summary Capture Vascular Inc (Capture Vascular) is a medical device development company that develops and commercializes mechanical thrombectomy systems. The company offers MegaVac, a mechanical thrombectomy system that removes clots in arteries and provides vessel occlusion, embolic prevention and …
  • Artilium plc (ARTA):企業の財務・戦略的SWOT分析
    Summary Artilium Plc (Artilium) is a technology company that offers mobile telecommunications software solutions. The company offers mobile virtual network enabler software solutions through its own state of the art cloud platform. It MVNE includes private LTE networks, MVNO in box, oneapp and multi …
  • Alcoa Corp:企業のM&A・事業提携・投資動向
    Alcoa Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Alcoa Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • IVERIC bio Inc (ISEE):企業の財務・戦略的SWOT分析
    Summary IVERIC bio Inc (IVERIC bio) formerly known as Ophthotech Corp, is a biopharmaceutical company that develops novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. The company’s products include Zimura, a complement inhibitor for stargardt di …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆